Price $0.77 |
Market Cap
45.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.07
|
P/S
2.39
|
Dividend %
-
|
|
P/CF
8.2
|
P/FCF
-
|
Op. Cash Flow
-16.6K
|
FCF
-0.2
|
|
Op. Margin
-170.70%
|
Net Margin
-170.80%
|
ROE
-103.20%
|
ROI
-76.90%
|
|
ROA
-73.70%
|
EPS Growth
37.10%
|
Current Ratio
1.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bioanalytical Systems, Inc. (BASI) | $4.84 | - | - | 51.6M | Strong Buy |
| Endo International PLC (ENDP) | $3.14 | - | - | 641.2M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.81 | - | - | 70.1M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $8.85 | - | - | 10.43B | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.64 | - | - | 38.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
